Skip to content

Effectiveness of memantine on opioid-induced hyperalgesia in opioid addict patients

Effectiveness of memantine on opioid-induced hyperalgesia in opioid addict patients

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20211112053045N1
Enrollment
34
Registered
2021-12-07
Start date
2021-12-22
Completion date
Unknown
Last updated
2022-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Effectiveness of memantine on OIH in opioid addict patients.

Interventions

Intervention 1: Intervention group: 18 to 60 years old opioid addict patients in Beheshti hospital with intake of enough analgesics from NSAIDS with maximum allowed dose, that have complaints of pain,

Sponsors

Zanjan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: opioid addict patients from 18 to 60 years old filling satisfaction form no multi substance use in patients no neurologic or nephrologic dysfunction no unstable medical states no Raynauds disease

Exclusion criteria

Exclusion criteria: use other substance such as stimulants memantine allergy pregnancy

Design outcomes

Primary

MeasureTime frame
Severity of pain ranking by patients from 0 to 10. Timepoint: checking of patients one day before start memantine & at the end of second & forth week after treatment. Method of measurement: ranking by patients from 0 to 10.;Time of stay patients hand in cold water. Timepoint: checking of patients one day before start memantine & at the end of second & forth week after treatment. Method of measurement: Cold pressor test time in seconds.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAhmad Zolghadriha

Zanjan University of Medical Sciences

Ahmad_zolghadriha@yahoo.com009833544000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026